JOHNSON & JOHNSON

JNJ New York Stock Exchange

275,23 $

Last updated: 2026-09-07

Johnson & Johnson is a global healthcare company focused on Innovative Medicine and MedTech. Through science-based innovation, the company develops medicines and medical technologies designed to prevent, treat and cure complex diseases while delivering smarter, less invasive and more personalized healthcare solutions.

Dividend (2025)

5,14 $

Yield (2025)

1,87 %

Market Cap

663.28B $

P/E Ratio

31,91

Dividend History

Link: investor.jnj.com/stock-info/def...

Year	Dividend	Yield
2025	5,14 $	—
2024	4,91 $	—
2023	4,70 $	—
2022	4,45 $	—
2021	4,19 $	—

Dividend growth rate: 5.24% (4-year CAGR)

Quick Analysis

Dividend Score 5/10

Key Insights

Consistent dividend history

Continue after this ad

News

Stocks Aug 10

JOHNSON & JOHNSON — New York Stock Exchange (NYSE)

Johnson & Johnson joins our list of companies with regular, stable or growing dividends. The U.S. healthcare group operates through Innovative Medicine and MedTech, with activities in pharmaceuticals, medical devices and major therapeutic areas, and trades under the ticker JNJ.

See more finance news